EU MDR approval is expected by about September this year. TGA considers that data in the application for regulatory approval in Australia and if this is data is accepted, turn around time for TGA approval can be in as little as a month or two. TGA takes EU MDR approval seriously.
FDA approval which is also aim of Oncosil is also going to play a major role in opening different markets and expansion possibilities around the world. Market Cap as well as stock price should reflect this.
Ann: Australian institution to invest $2.7 million in OSL, page-38
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(4.17%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.2¢ | 1.2¢ | $3.318K | 277.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4850000 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 4285138 | 10 |
View Market Depth
| Last trade - 11.01am 04/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |